PFT
GILD icon

Providence First Trust’s Gilead Sciences GILD Stock Holding History

Providence First Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Sell
3,775
-1,849
-33% -$244K 0.13% 149
2026
Q1 		$784K Sell
5,624
-950
-14% -$133K 0.28% 83
2025
Q4 		$807K Buy
+6,574
New +$799K 0.28% 82
2025
Q1 		– Sell
-19,471
Closed -$1.8M – 136
2024
Q4 		$1.8M Buy
+19,471
New +$1.75M 0.68% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Providence First Trust's GILD Position: Q2 2026 in Review

Providence First Trust reduced its Gilead Sciences (GILD) stake by 33% in Q2 2026, selling an estimated $244K and leaving 3,775 shares worth $477K. The position accounts for 0.13% of the portfolio, ranked #149.

Providence First Trust first reported a position in GILD in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.8M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Providence First Trust held 3,775 shares of Gilead Sciences worth $477K as of Q2 2026.
  • Providence First Trust sold 1,849 Gilead Sciences shares in Q2 2026, an estimated $244K.
  • Gilead Sciences made up 0.13% of Providence First Trust's portfolio in Q2 2026, its #149 holding.
  • Providence First Trust first reported a position in Gilead Sciences in Q4 2024 and has held it in 4 quarters since.
  • Providence First Trust's Gilead Sciences position peaked at $1.8M in Q4 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Providence First Trust's 13F filing for Q2 2026, filed 27 Jul 2026.